What's in Innovative Medical's pipeline?

Innovative Medical has 16 drugs in our index: 16 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Innovative Medical's portfolio?

Top competitors by shared drug class: Alk Abello, International Association Psychosomatics And Health Therapy, National University of Malaysia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/innovative-medical.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Innovative Medical — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Innovative Medical pipeline: 16 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

16 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Viscoat	Viscoat	marketed			Other
Gatifloxacin 0.3%	Gatifloxacin 0.3%	marketed	Fluoroquinolone	DNA gyrase and topoisomerase IV	Infectious Disease
Refresh Tears, 9582X	Refresh Tears, 9582X	marketed
0.15% sodium Hyaluronate	0.15% sodium Hyaluronate	marketed
Dermatix Q	Dermatix Q	marketed
Acular, Xibrom	Acular, Xibrom	marketed
Bimatoprost 0.03%, Latanoprost	Bimatoprost 0.03%, Latanoprost	marketed
FreshKote	FreshKote	marketed
Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost	Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost	marketed
1. Optive	1. Optive	marketed
Propylene Glycol 0.3%	Propylene Glycol 0.3%	marketed
Ketorolac, Nepafenac	Ketorolac, Nepafenac	marketed

Therapeutic area mix

Other · 3
Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Alk Abello · 1 shared drug class
International Association Psychosomatics And Health Therapy · 1 shared drug class
National University of Malaysia · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Innovative Medical:

Cite this brief

Drug Landscape (2026). Innovative Medical — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/innovative-medical. Accessed 2026-05-17.